127. Dr. Mink Chawla: Blood Filter Seraph 100 Shows Promise To End Long COVID

The Seraph-100 blood filtration device utilizes surface affinity to remove pathogens, inflammatory mediators, and circulating tumor cells from the bloodstream, functioning as a sophisticated decoy that mimics the endothelial glycocalyx. By reducing the immune system's chronic overload—often caused by persistent viral loads, environmental toxins, and metabolic stressors—this subtractive technology allows the body to reallocate resources toward healing and surveillance. Dr. Mink Chawla, an ICU physician and nephrologist, highlights the device's potential in addressing long COVID and metastatic cancer by clearing harmful particles that evade standard pharmaceutical interventions. Furthermore, the discussion addresses concerns regarding mRNA vaccine-induced spike protein production and frameshift proteins, proposing that blood filtration could provide a necessary therapeutic intervention for patients suffering from treatment-resistant conditions, effectively resetting the immune system's ability to defend against disease and slow the progression of aging.